Leading Research Center serving the Greater Sherman Area
Join a Clinical Trial
ASTHMA: Flair Study
The FLAIR Study is evaluating an investigational drug to see how it works in reducing the severity and frequency of “asthma attacks” in children, adolescents, and adults. The investigational drug will be administered using an inhaler device.
We are currently looking for people aged 40 years and older with COPD who have experienced at least 1 flare-up requiring treatment in the last 12 months, despite taking daily inhaled maintenance therapy, to participate in an important treatment study.
You may want to consider participating in the HERMES study, evaluating a new investigational drug for its ability to treat inflammation which may have a positive effect on heart failure.
Participating in a clinical trial gives patients access to medications of the future for the diseases of today.
By meeting with our research team for a prescreening appointment, we can discuss which research programs you may be eligible for. These programs are at no cost to patients and do not involve their insurance. Some programs may reimburse patients for their participation.
Pharmaceutical Sponsor?
We have worked with sponsors such as AstraZeneca, Pfizer, Glaxo Smith Kline, Rebiotix, Novo Nordisk, and Janssen.
If you are a sponsor who would like to learn more about our site:
.png){kind=small}
